Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug 1;2013(8):CD006484.
doi: 10.1002/14651858.CD006484.pub3.

Influenza vaccination in children being treated with chemotherapy for cancer

Ginette M Goossen  1 , Leontien C M Kremer, Marianne D van de Wetering
Affiliations

Influenza vaccination in children being treated with chemotherapy for cancer

Ginette M Goossen et al. Cochrane Database Syst Rev. .

Abstract

Background: Influenza infection is a potential cause of severe morbidity in children with cancer; therefore vaccination against influenza is recommended. However, data are conflicting regarding the immune response to influenza vaccination in children with cancer, and the value of vaccination remains unclear.

Objectives: 1. To assess the efficacy of influenza vaccination in stimulating an immunological response in children with cancer during chemotherapy, compared with control groups.2. To assess the efficacy of influenza vaccination in preventing confirmed influenza and influenza-like illness and/or in stimulating immunological response in children with cancer treated with chemotherapy, compared with placebo, no intervention or different dosage schedules.3. To identify the adverse effects associated with influenza vaccines in children with cancer treated with chemotherapy, compared with other control groups.

Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (1966 to 2012) and EMBASE (1980 to 2012) up to August 2012. We also searched reference lists of relevant articles and conference proceedings of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), the Infectious Diseases Society of America (IDSA), the Multinational Association of Supportive Care in Cancer (MASCC) and the International Society of Paediatric Oncology (SIOP).

Selection criteria: We considered randomised controlled trials (RCTs) and controlled clinical trials (CCTs) in which the serological response to influenza vaccination of children with cancer was compared with that of control groups. We also considered RCTs and CCTs that compared the effects of influenza vaccination on clinical response and/or immunological response in children with cancer being treated with chemotherapy, compared with placebo, no intervention or different dosage schedules.

Data collection and analysis: Two independent review authors assessed the methodological quality of included studies and extracted the data.

Main results: We included 1 RCT and 9 CCTs (total number of participants = 770). None of the included studies reported clinical outcomes. All included studies reported on influenza immunity and adverse reactions to vaccination. In five studies, immune responses to influenza vaccine were compared in 272 children receiving chemotherapy and 166 children not receiving chemotherapy. In four studies, responses to influenza vaccine were assessed in 236 children receiving chemotherapy compared with responses in 142 healthy children. Measures used to assess immune responses included a four-fold rise in antibody titre after vaccination, development of a haemagglutination inhibition (HI) titre > 32 and pre- and post-vaccination geometric mean titres (GMTs). Immune responses in children receiving chemotherapy were consistently weaker (four-fold rise of 38% to 65%) than those in children who had completed chemotherapy (50% to 86%) and in healthy children (53% to 89%). In terms of adverse effects, 391 paediatric oncology patients received influenza vaccine, and the adverse effects described included mild local reactions and low-grade fever. No life-threatening or persistent adverse effects were reported.

Authors' conclusions: Paediatric oncology patients receiving chemotherapy are able to generate an immune response to the influenza vaccine, but it remains unclear whether this immune response protects them from influenza infection or its complications. We are awaiting results from well-designed RCTs addressing the clinical benefit of influenza vaccination in these patients.

PubMed Disclaimer

Conflict of interest statement

None.

Update of

References

References to studies included in this review

Chisholm 2001 {published data only}
    1. Chisholm JC, Devine T, Charlett A, Pinkerton CR, Zoambon M. Response to influenza immunisation during treatment for cancer. Archives of Disease in Childhood 2001;84(6):496‐500. - PMC - PubMed
Chisholm 2005 {published data only}
    1. Chisholm J, Howe K, Taj M, Zambon M. Influenza immunization in children with solid tumours. European Journal of Cancer 2005;41(15):2280‐7. - PubMed
Gross 1978 {published data only}
    1. Gross PA, Lee H, Wolff JA, Hall CB, Minnefore AB, Lazicki ME. Influenza immunization in immunosuppressed children. Journal of Pediatrics 1978;92(1):30‐5. - PubMed
Hsieh 2002a {published data only}
    1. Hsieh Y, Lu MY, Kao CL, Chiang BL, Lin DT, Lin KS, et al. Response to influenza vaccine in children with leukemia undergoing chemotherapy [RCT]. Journal of the Formosan Medical Association 2002;101(10):700‐4. - PubMed
Hsieh 2002b {published data only}
    1. Hsieh Y, Lu MY, Kao CL, Chiang BL, Lin DT, Lin KS, et al. Response to influenza vaccine in children with leukemia undergoing chemotherapy [CCT]. Journal of the Formosan Medical Association 2002;101(10):700‐4. - PubMed
Lange 1979 {published data only}
    1. Lange B, Shapiro SA, Waldman MT, Proctor E, Arbeter A. Antibody responses to influenza immunization of children with acute lymphoblastic leukemia. Journal of Infectious Diseases 1979;140(3):402‐6. - PubMed
Matsuzaki 2005 {published data only}
    1. Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T. Immune response after influenza vaccination in children with cancer. Pediatric Blood & Cancer 2005;45(6):831‐7. - PubMed
Porter 2004 {published data only}
    1. Porter CC, Edwards KM, Zhu Y, Frangoul H. Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia. Pediatric Blood & Cancer 2004;42(1):36‐40. - PubMed
Shahgholi 2010 {published data only}
    1. Shahgholi E, Ehsahni MA, Salamati P, Maysamie A, Sotoudeh K, Mokhtariazad T. Immunogenicity of trivalent influenza vaccine in children with acute lymphoblastic leukemia during maintenance therapy. Pediatric Blood and Cancer 2010;54(5):716‐20. - PubMed
Steinherz 1980 {published data only}
    1. Steinherz PG, Brown AE, Gross PA, Braun D, Ghavimi F, Wollner N, et al. Influenza immunization of children with neoplastic diseases. Cancer 1980;45(4):750‐6. - PubMed

References to studies excluded from this review

Adell 2002 {published data only}
    1. Adell C, Bayas JM, Vilella A, Perales M, Vidal J, Bertran MJ, et al. Post‐transplantation vaccination of bone‐marrow transplant recipients [Vacunación de pacientes receptores de trasplante de progenitores hemotopyéticos]. Medicina Clínica 2002;119(11):405‐9. - PubMed
Ahmed 1996 {published data only}
    1. Ahmed AH, Nicholson KG. The efficacy of influenza vaccine. Reviews in Medical Microbiology 1996;7(1):23‐30.
Allison 1977 {published data only}
    1. Allison JE, Glezen WP, Taber LH, Paredes A, Webster RG. Reactogenicity and immunogenicity of bivalent influenza A and monovalent influenza B virus vaccines in high‐risk children. Journal of Infectious Diseases 1977;136 Suppl:S672‐6. - PubMed
Arola 1995 {published data only}
    1. Arola M, Ruuskanen O, Ziegler T, Salmi TT. Respiratory virus infections during anticancer treatment in children. Pediatric Infectious Disease Journal 1995;14(8):690‐4. - PubMed
Barnes 2001 {published data only}
    1. Barnes R, Stallard N. Severe infections after bone marrow transplantation. Current Opinion in Critical Care 2001;7(5):362‐6. - PubMed
Bektas 2007 {published data only}
    1. Bektas O, Karadeniz C, Oguz A, Berberoglu S, Berberoglu S, Yilmaz N, et al. Assessment of the immune response to trivalent split influenza vaccine in children with solid tumors. Pediatric Blood and cancer 2007;49(7):914‐7. - PubMed
Borella 1971 {published data only}
    1. Borella L, Webster RG. The immunosuppressive effects of long‐term combination chemotherapy in children with acute leukemia in remission. Cancer Research 1971;31(4):420‐6. - PubMed
Brown 1982 {published data only}
    1. Brown AE, Steinherz PG, Miller DR, Armstrong D, Kellick G, Gross PA, et al. Immunization against influenza in children with cancer: results of a three‐dose trial. Journal of Infectious Diseases 1982;145(1):126. - PubMed
Brown 1983 {published data only}
    1. Brown AE. Influenza and pneumococcal immunization of patients with neoplastic diseases. Schweizerische Medizinische Wochenschrift Supplementum 1983;14:30‐4. - PubMed
Brunell 1977 {published data only}
    1. Brunell PA. Immunologic response of immunosuppressed children to influenza vaccine. Morbidity and Mortality Weekly Report 1977;26:54.
Brydak 1997 {published data only}
    1. Brydak LB, Rokicka‐Milewska R, Jackowska T, Rudnicka H, Regnery H, Cox N. Kinetics of humoral response in children with acute lymphoblastic leukemia immunized with influenza vaccine in 1993 in Poland. Leukemia and Lymphoma 1997;26(1‐2):163‐9. - PubMed
Brydak 1998 {published data only}
    1. Brydak LB, Rokicka‐Milewska R, Machala M, Jackowska T, Sikorska‐Fic B. Immunogenicity of subunit trivalent influenza vaccine in children with acute lymphoblastic leukemia. Pediatric Infectious Disease Journal 1998;17(2):125‐9. - PubMed
Engelhard 1993 {published data only}
    1. Engelhard D, Nagler A, Hardan I, Morag A, Aker M, Baciu H, et al. Antibody response to a two‐dose regimen of influenza vaccine in allogeneic T cell‐depleted and autologous BMT recipients. Bone Marrow Transplantation 1993;11(1):1‐5. - PubMed
Esposito 2009 {published data only}
    1. Esposito S, Cecinati V, Russo FG, Principi N. Influenza vaccination in children with cancer receiving chemotherapy. Human Vaccination 2009;5(6):430‐2. - PubMed
Feery 1979 {published data only}
    1. Feery BJ, Matthews RN, Evered MG, Gallichio HA. Antibody responses to influenza virus vaccine in patients with acute lymphocytic leukaemia. Australian Paediatric Journal 1979;15(3):177‐80. - PubMed
Ganz 1978 {published data only}
    1. Ganz PA, Shanley JD, Cherry JD. Responses of patients with neoplastic diseases to influenza virus vaccine. Cancer 1978;42(5):2244‐7. - PubMed
Gribabis 1994 {published data only}
    1. Gribabis DA, Panayiotidis P, Boussiotis VA, Hannoun C, Pangalis GA. Influenza virus vaccine in B‐cell chronic lymphocytic leukaemia patients. Acta Haematologica 1994;91(3):115‐8. - PubMed
Gross 1985 {published data only}
    1. Gross PA, Gould AL, Brown AE. Effect of chemotherapy on the immune response to influenza virus vaccine: review of published studies. Review of Infectious Diseases 1985;7(5):613‐8. - PubMed
Hayden 2000 {published data only}
    1. Hayden FG. Advances in the prophylaxis and treatment of influenza illness. American Journal of Managed Care 2000;6(5 Suppl):S247‐54. - PubMed
Hicks 2003 {published data only}
    1. Hicks KL, Chemaly RF, Kontoyiannis DP. Common respiratory viruses in patients with cancer: more than just "common colds". Cancer 2003;97(10):2576‐87. - PubMed
Jackowska 1996 {published data only}
    1. Jackowska T, Brydak L, Rokicka‐Milewska R, Lukowska K, Gosk B, Rudnicka H, et al. Vaccination against influenza in children with acute lymphoblastic leukaemia [Szczepienia przeciw grypie dzieci chorych na ostra bialaczke limfoblastyczna]. Pediatria Polska 1996;71(4):302‐6. - PubMed
Kandel 2005 {published data only}
    1. Kandel R, Hartshorn KL. Novel strategies for prevention and treatment of influenza. Expert Opinion on Therapeutic Targets 2005;9(1):1‐22. - PubMed
Kempe 1989 {published data only}
    1. Kempe A, Hall CB, MacDonald NE, Foye HR, Woodin KA, Cohen HJ, et al. Influenza in children with cancer. Journal of Pediatrics 1989;115(1):33‐9. - PubMed
Louie 2006 {published data only}
    1. Louie JK, Schechter R, Honarmand S, Guevara HF, Schoemaker TR, Madrigal NY, et al. Severe pediatric influenza in California, 2003‐2005: implications for immunization recommendations. Pediatrics 2006;117(4):e610‐8. - PubMed
Mayr 1974 {published data only}
    1. Mayr AC, Nagel GA, Dick HJ, Pavlicek LP. Proceedings: influenza vaccination in patients with cancer? [Grippeschutzimpfung bei Tumorpatienten?]. Helvetica Medica Acta 1974;37(5‐6):395. - PubMed
McIntosh 2003 {published data only}
    1. McIntosh ED, Paradiso PR. Recent progress in the development of vaccines for infants and children. Vaccine 2003;21(7‐8):601‐4. - PubMed
Modlin 1977 {published data only}
    1. Modlin JF, Smith DH, Harding L. Clinical trials of bivalent A/New Jersey/76‐A/Victoria/75 influenza vaccines in high‐risk children. Journal of Infectious Diseases 1977;136 Suppl:S626‐31. - PubMed
Morris 1990 {published data only}
    1. Morris DJ. Virus infections in children with cancer. Reviews in Medical Microbiology 1990;1(1):49‐57.
Pauksen 2000 {published data only}
    1. Pauksen K, Linde A, Hammarström V, Sjölin J, Carneskog J, Jonsson G, et al. Granulocyte‐macrophage colony‐stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clinical Infectious Diseases 2000;30(2):342‐8. - PubMed
Reilly 2010 {published data only}
    1. Reilly A, Kersun LS, McDonald K, Weinberg A, Jawad AF, Sullivan KE. The efficacy of influenza vaccination in a pediatric oncology population. Journal of Pediatric Hematology Oncology 2010;32(5):e177‐81. - PubMed
Ridgway 1993 {published data only}
    1. Ridgway D, Wolff LJ. Active immunisation of children with leukemia and other malignancies. Leukemia and Lymphoma 1993;9(3):177‐92. - PubMed
Schafer 1979 {published data only}
    1. Schafer AI, Churchill WH, Ames P, Weinstein L. The influence of chemotherapy on response of patients with hematologic malignancies to influenza vaccine. Cancer 1979;43(1):25‐30. - PubMed
Smithson 1978 {published data only}
    1. Smithson WA, Siem RA, Ritts RE, Gilchrist GS, Burgert EO, Ilstrup DM, et al. Response to influenza virus vaccine in children receiving chemotherapy for malignancy. Journal of Pediatrics 1978;93(4):632‐4. - PubMed
Somani 1995 {published data only}
    1. Somani J, Larson RA. Reimmunization after allogeneic bone marrow transplantation. American Journal of Medicine 1995;98(4):389‐98. - PubMed
Stiver 1978 {published data only}
    1. Stiver HG, Weinerman BH. Impaired serum antibody response to inactivated influenza A and B vaccine in cancer patients. Canadian Medical Association Journal 1978;119(7):733‐8. - PMC - PubMed
Sumaya 1977 {published data only}
    1. Sumaya CV, Williams TE, Brunell PA. Bivalent influenza vaccine in children with cancer. Journal of Infectious Diseases 1977;136 Suppl:S656‐60. - PubMed
Sumaya 1982 {published data only}
    1. Sumaya CV, Williams TE. Persistence of antibody after the administration of influenza vaccine to children with cancer. Pediatrics 1982;69(2):226‐9. - PubMed
Uchaikin 1999 {published data only}
    1. Uchaikin VF, Skachkova LO, Shamsheva OV, Smirnov AV, Polesko IV, Lezhneva LN, et al. The vaccination of children with severe somatic pathology [Vaktsinatsiia detei s tiazheloi somaticheskoi patologiei]. [Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii] 1999;4:30‐4. - PubMed
Yamada 1982 {published data only}
    1. Yamada A, Yamawaki H, Tsuda N, Baba K, Yabuuchi H, Maeda A, et al. Trial of split‐product trivalent influenza vaccine in high risk children. Biken Journal 1982;25(2):89‐95. - PubMed

Additional references

Cochrane Handbook
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. The Cochrane Library, Issue 3. Chichester, UK: John Wiley & Sons, Ltd, 2005.
Collins 2000
    1. Collins J, Byrnes M, Dunkel I, Lapin J, Nadel T, Thaler H, et al. The measurement of symptoms in children with cancer. Journal of Pain and Symptom Management 2000;19(5):323‐77. - PubMed
Dykewicz 2001
    1. Dykewicz CA. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: focus on community respiratory virus infections. Biology of Blood and Marrow Transplantation 2001;7 Suppl:19S‐22S. - PubMed
Feldman 1977
    1. Feldman S, Webster RG, Sugg M. Influenza in children and young adults with cancer. Cancer 1977;39:350‐3. - PubMed
Fiore 2010
    1. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. Morbidity and Mortality Weekly Report; Recommendations and Reports 2010;59(31):1‐62. - PubMed
Higgins 2008
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0 [updated July 2008]. The Cochrane Collaboration.www.cochrane‐handbook.org, 2008.
Karadeniz 2005
    1. Karadeniz C, Karadeniz C, Bektas O, Oguz A, Berberoglu S, Yy’maz N, et al. P.G1.015 Responses of children with solid tumours to influenza virus vaccine. 37th Annual Conference of the International Society of Paediatric Oncology, SIOP 2005, Vancouver, Canada, 21‐24 September 2005. Pediatric Blood & Cancer. 2005; Vol. 45:4.
NOS 2007
    1. Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta‐analyses, 2007. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
Potter 1991
    1. Potter MN, Foot ABM, Oakhill A. Influenza A and the virus associated haemophagocytic syndrome: cluster of three cases in children with acute leukaemia. Journal of Clinical Pathology 1991;44:297‐9. - PMC - PubMed
Raad 1997
    1. Raad I, Abbas J, Whimbey E. Infection control of nosocomial respiratory viral disease in the immunocompromised host. American Journal of Medicine 1997;102:48‐52. - PubMed
RevMan 2008 [Computer program]
    1. The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). Version 5.0. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2008.
Ring 2002
    1. Ring A, Gavin M, Steer C, Harper P. Influenza vaccination and chemotherapy: a shot in the dark?. Supportive Care in Cancer 2002;10:462‐5. - PubMed
Sandherr 2006
    1. Sandherr M, Einsele H, Hebart H, Kahl C, Kern W, Kiehl M, et al. Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO). Annals of Oncology 2006;17(7):1051‐9. - PubMed

References to other published versions of this review

Goossen 2007
    1. Goossen GM, Kremer LCM, Wetering MD. Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD006484] - DOI - PubMed
Goossen 2009
    1. Goossen GM, Kremer LCM, Wetering MD. Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD006484.pub2] - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources